Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer

被引：0
|
作者：
Mario Campone
Maria Blasinska-Morawiec
Anna Tekiela
Piotr Koralewski
Jean-Christophe Pouget
Isabelle Douville
Maud Brandely
机构：
[1] Centre René Gauducheau,
[2] Service Oncologie Médicale,undefined
[3] Wojewodzki Szpital Specjalistyczny im. M. Kopernika,undefined
[4] Wojewodzki Szpital Specjalistyczny im. L. Rydygiera,undefined
[5] Institut de Recherche Pierre Fabre,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Metastatic breast cancer; Oral vinorelbine; Docetaxel; Oral chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer
    Campone, Mario
    Blasinska-Morawiec, Maria
    Tekiela, Anna
    Koralewski, Piotr
    Pouget, Jean-Christophe
    Douville, Isabelle
    Brandely, Maud
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (05) : 937 - 943
  • [2] Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer
    M. Vassilomanolakis
    G. Koumakis
    S. Drufakou
    G. Aperis
    M. Demiri
    V. Barbounis
    J. Missitzis
    A. Efremidis
    [J]. Cancer Chemotherapy and Pharmacology, 2003, 51 : 179 - 183
  • [3] Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer
    Vassilomanolakis, M
    Koumakis, G
    Drufakou, S
    Aperis, G
    Demiri, M
    Barbounis, V
    Missitzis, J
    Efremidis, AP
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (02) : 179 - 183
  • [4] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Liang Huang
    Xiaojia Wang
    Liheng Zhou
    Lijun Di
    Hongyu Zheng
    Zefei Jiang
    Yongsheng Wang
    Xiangqun Song
    Jifeng Feng
    Shiying Yu
    Yunpeng Liu
    Hong Zheng
    Kunwei Shen
    Zhongsheng Tong
    Zhimin Shao
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 85 : 205 - 215
  • [5] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Huang, Liang
    Wang, Xiaojia
    Zhou, Liheng
    Di, Lijun
    Zheng, Hongyu
    Jiang, Zefei
    Wang, Yongsheng
    Song, Xiangqun
    Feng, Jifeng
    Yu, Shiying
    Liu, Yunpeng
    Zheng, Hong
    Shen, Kunwei
    Tong, Zhongsheng
    Shao, Zhimin
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 205 - 215
  • [6] Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
    D Serin
    M Verrill
    A Jones
    T Delozier
    R Coleman
    E-D Kreuser
    K Mross
    B Longerey
    M Brandely
    [J]. British Journal of Cancer, 2005, 92 : 1989 - 1996
  • [7] Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
    Serin, D
    Verrill, M
    Jones, A
    Delozier, T
    Coleman, R
    Kreuser, ED
    Mross, K
    Longerey, B
    Brandely, M
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (11) : 1989 - 1996
  • [8] Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy
    Freyer, G
    Delozier, T
    Lichinister, M
    Gedouin, D
    Bougnoux, P
    His, P
    Imadalou, K
    Trillet-Lenoir, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 35 - 40
  • [9] A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer
    Cresta, S
    Grasselli, G
    Mansutti, M
    Martoni, A
    Lelli, G
    Capri, G
    Buzzi, F
    Della Cuna, GR
    Jirillo, A
    Terzoli, E
    Frevola, L
    Tarenzi, E
    Sguotti, C
    Azli, N
    Murawsky, M
    Gianni, L
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 433 - 439
  • [10] Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer
    Ferrario, Cristiano
    Strepponi, Ivan
    Esfahani, Khashayar
    Charamis, Helen
    Langleben, Adrian
    Scarpi, Emanuela
    Nanni, Oriana
    Miller, Wilson H., Jr.
    Panasci, Lawrence C.
    [J]. PLOS ONE, 2016, 11 (12):
12345